Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety

Sponsor
University of Denver (Other)
Overall Status
Recruiting
CT.gov ID
NCT04245501
Collaborator
National Institute of Mental Health (NIMH) (NIH), University of California, Los Angeles (Other)
46
1
2
26.7
1.7

Study Details

Study Description

Brief Summary

Anxiety is the most common mental health problem in children and adolescents. This two-phased study will test the effects of an experimental computerized intervention aimed at reducing threat-based thinking (i.e., interpretation bias) in anxious youth. Participants in both the R61 (N=46) and R33 (N=72) trials will be youth ages 10 to 17 with a primary anxiety disorder (Separation, Social, Generalized). In the R61 trial, youth will be randomly assigned to receive 16 sessions over 4 weeks of either a personalized cognitive bias modification program for interpretation bias (CBM-I) or a computerized control condition (ICC). If CBM-I reduces interpretation bias significantly more than the ICC, the R33 trial will commence. In the R33, youth will be randomly assigned to either CBM-I or an equal amount of time in a cognitive restructuring intervention, which also aims to reduce threat-based thinking in anxiety.

Condition or Disease Intervention/Treatment Phase
  • Other: Cognitive Bias Modification for Interpretations (CBM-I)
  • Other: Interpretation Control Condition (ICC)
N/A

Detailed Description

Anxiety is the most common mental health problem in youth, affecting one in four children and adolescents. Unfortunately, evidence-based treatments (pharmacotherapy, cognitive-behavioral therapy) are costly, not widely available, and ineffective for a substantial proportion of youth. In response, experts have called for novel treatments that directly target mechanisms underlying youth anxiety while simultaneously addressing barriers to care (i.e., cost, accessibility). One such promising mechanism is interpretation bias - the inaccurate interpretation of threat from ambiguity. The investigators have previously demonstrated that interpretation bias occurs in over 90% of anxious youth, is predictive of anxiety severity in clinical samples of youth, and differentiates between anxious and non-anxious youth. These data indicate that interpretation bias may be a ubiquitous phenomenon underlying anxiety expression in children and adolescents and therefore may be an ideal intervention target. Cognitive bias modification for interpretation bias (CBM-I) is a computerized intervention that attempts to reduce anxiety by directly modifying interpretation bias. CBM-I has demonstrated preliminary efficacy for reducing anxiety symptoms in adults. Yet extant CBM-I data in anxious youth are sparse, with little work addressing whether CBM-I significantly reduces interpretation bias, and whether this in turn reduces anxiety symptoms, as well as the dose necessary to reduce both bias and anxiety. This two-phased study tests personalized CBM-I in youth ages 10 to 17 who meet diagnostic criteria for a primary anxiety disorder (Separation, Social, Generalized). In the R61 Phase (N=46), a randomized clinical trial (RCT) examines whether CBM-I personalized to youth anxiety symptoms significantly reduces interpretation bias compared to a computerized interpretation control condition (ICC). The interpretation target will be measured at multiple time points (4, 8, 12, 16 sessions) to identify the optimal dose for reduction in interpretation bias. If the R61 trial results indicate that CBM-I outperforms ICC on interpretation bias reduction, the R33 phase will commence. In the R33 Phase, an RCT (N=72) will validate whether CBM-I significantly reduces interpretation bias, and conducts a mechanism test (i.e., does bias reduction precede and predict anxiety reduction?), by comparing CBM-I to cognitive restructuring, a clinically relevant psychosocial intervention that also targets anxious cognition.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Eligible youth will be randomly assigned to receive either 16 sessions of a personalized cognitive bias modification for interpretation bias (CBM-I) intervention or a computerized interpretation control condition (ICC). Regardless of randomization, participants will complete 16 sessions of their assigned condition within 4 weeks (1 in-lab training per week, and 3 at-home trainings per week).Eligible youth will be randomly assigned to receive either 16 sessions of a personalized cognitive bias modification for interpretation bias (CBM-I) intervention or a computerized interpretation control condition (ICC). Regardless of randomization, participants will complete 16 sessions of their assigned condition within 4 weeks (1 in-lab training per week, and 3 at-home trainings per week).
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Both participants and outcome assessors will be blind to condition. Unblinding occurs following all post-intervention assessment (i.e., after 16 CBM-I or ICC sessions).
Primary Purpose:
Treatment
Official Title:
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety
Actual Study Start Date :
Jun 20, 2020
Anticipated Primary Completion Date :
Sep 10, 2022
Anticipated Study Completion Date :
Sep 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Bias Modification for Interpretations (CBM-I)

Computerized 16-session intervention aimed at reducing interpretation bias. In this study, CBM-I is personalized to youth anxiety symptoms. During CBM-I sessions, youth indicate whether word-sentence pairs are related, and are provided with feedback aimed to reduce bias.

Other: Cognitive Bias Modification for Interpretations (CBM-I)
Computerized intervention in which youth see word-sentence pairs personalized to their anxiety symptoms, and indicate whether these are related. Youth receive feedback aimed to reduce interpretation bias.
Other Names:
  • Interpretation bias modification
  • Interpretation training
  • Placebo Comparator: Interpretation Control Condition (ICC)

    Computerized 16-session intervention that is not believed to significantly modify bias. In this study, youth see stimuli personalized to their anxiety symptoms. During ICC sessions, youth see word-sentence pairs and are required to indicate whether word and sentence are related, but are not provided with feedback that aims to "train" a reduction in interpretation bias.

    Other: Interpretation Control Condition (ICC)
    Computerized control condition in which youth see word-sentence pairs personalized to their anxiety symptoms. Youth indicate whether these are related, but are not provided with feedback that aims to "train" a reduction in interpretation bias.

    Outcome Measures

    Primary Outcome Measures

    1. Change in linguistic interpretation bias as assessed by the word-sentence association paradigm for youth (WSAP-Y) [baseline, 6 weeks]

      The WSAP-Y is a computerized assessment of interpretation bias in which youth indicate whether word-sentence pairings are related. This measure provides information about the degree to which youth evidence interpretation bias, as well as a behavioral (reaction time) index for bias endorsement.

    2. Change in visual interpretation bias as assessed by the ambiguous faces task [baseline, 6 weeks]

      Youth view faces portraying neutral expressions or subtle emotional expressions (i.e., morphed faces ranging in intensity of emotional valence). Youth categorization of faces as neutral or threatening provides their sensitivity and bias for reporting presence of threat.

    3. Change in self-reported interpretation bias as measured by the Children's Automatic Thoughts Scale (CATS) [baseline, 6 weeks]

      The Children's Automatic Thoughts Scale is a youth self-report questionnaire which assesses presence and frequency of a variety of anxious thoughts from domains of: physical threat, social threat, personal failure, and anxious hostility. Total scores range from 0 to 160, with higher scores indicating more threat interpretations (i.e., worse score).

    Secondary Outcome Measures

    1. Feasibility of CBM-I: Proportion of CBM-I trainings completed of 16 intended sessions. [baseline, 6 weeks]

      Proportion of CBM-I trainings completed of 16 intended sessions.

    2. Participant/Parent Acceptability Questionnaire (PAQ) [baseline, 6 weeks]

      The Participant Acceptability Questionnaire is a 10-item youth and parent report questionnaire, accompanied by an exit interview, that assesses burden (travel, boredom), credibility of computerized intervention techniques, and youth comprehension of the intervention.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • youth aged 10 to 17

    • diagnosed at study baseline with a primary "big three" anxiety disorder (Separation, Social, Generalized)

    • standard score greater than or equal to 85 on the Wide Range Achievement Test - Word Reading Subtest (to ensure ability to read stimuli during interpretation bias assessment and CBM-I/ICC), and estimated IQ standard score of at least 80 on the Wechsler Abbreviated Scale of Intelligence

    • youth and consenting parent/legal guardian speak sufficient English to complete consent/assent and study procedures

    • no concurrent psychosocial services during study participation to reduce likelihood that other interventions are responsible for change in primary or secondary outcomes

    • no psychotropic medications with no plans to start medications during study, or six weeks stable on SSRI or psychostimulant medication and dose with no plans to change medication/dose during study

    Exclusion Criteria:
    • severe anxiety indicting that youth requires higher level of care (e.g., intensive treatment such as psychiatric hospitalization), significant diagnostic comorbidity (e.g., presence of psychosis or significant mood disorder), or another primary diagnosis that warrants alternate intervention

    • significant uncorrected vision impairment (e.g., uncorrected blindness) that precludes participation in CBM-I/ICC

    • safety concerns due to recent or acute suicidality with plan, intent, and/or attempt that warrants alternate intervention

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 BRAVE Lab, Department of Psychology, University of Denver Denver Colorado United States 80210

    Sponsors and Collaborators

    • University of Denver
    • National Institute of Mental Health (NIMH)
    • University of California, Los Angeles

    Investigators

    • Principal Investigator: Michelle S Rozenman, Ph.D., University of Denver

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michelle Rozenman, Assistant Professor, Department of Psychology, University of Denver
    ClinicalTrials.gov Identifier:
    NCT04245501
    Other Study ID Numbers:
    • 1R61MH121552-01
    • 1R61MH121552
    First Posted:
    Jan 29, 2020
    Last Update Posted:
    Aug 18, 2020
    Last Verified:
    Aug 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Michelle Rozenman, Assistant Professor, Department of Psychology, University of Denver
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 18, 2020